Skip to main content
Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
1.340
-0.040 (-2.90%)
At close: Mar 9, 2026

EGX:MCRO Revenue

In the year 2025, Macro Group Pharmaceuticals (Macro Capital) S.A.E had annual revenue of 894.54M EGP with 72.04% growth. Macro Group Pharmaceuticals (Macro Capital) S.A.E had revenue of 216.28M in the quarter ending December 31, 2025, with 7.73% growth.

Revenue
894.54M
Revenue Growth
+72.04%
P/S Ratio
0.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
786.88M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025894.54M374.58M72.04%
Dec 31, 2024519.97M-6.04M-1.15%
Dec 31, 2023526.01M-203.61M-27.91%
Dec 31, 2022729.61M135.35M22.78%
Dec 31, 2021594.26M163.76M38.04%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
International Company for Leasing S.A.E. 415.96M
Middle East Glass Manufacturing Company S.A.E. 5.81B
The General Company for Ceramic and Porcelain Products 95.15M
Sabaa International Company for Pharmaceutical and Chemical Industry 54.07M
Giza General - Contracting and Real Estate Investment S.A.E 1.02B
Remco Tourism Villages Construction 5.96B
Unirab Polvara Spinning & Weaving Co. 92.62M
Cairo Oil & Soap Company 859.83M
Revenue Rankings